Nevada SB149 revises Medicaid pharmacy benefit management, including exemptions from step therapy for certain conditions and restrictions on state.
Nevada SB149 revises provisions governing the administration of pharmacy benefits under Medicaid. It allows for exemptions from step therapy for recipients diagnosed with stage 3 or 4 cancer or those needing antirejection medications for organ transplants, among others. The bill also restricts state pharmacy benefit managers from certain actions, such as using spread pricing or imposing different cost-sharing obligations for 340B drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.